Dr. Istvan Petak, founder and CEO of Genomate Health, will be speaking at the upcoming Clinical Informatics Grand Rounds hosted by Cancer Informatics for Cancer Centers (Ci4CC). This online event, scheduled for March 6 (12 pm PT / 3 pm ET), will bring together leaders in oncology and informatics to discuss the latest advancements shaping the future of cancer care.
Abstract: One of the most striking challenges in precision oncology is that each tumor contains, on average, 4 to 5 driver alterations and biomarkers from millions of potential mutations among over 700 cancer driver genes. To gather the necessary evidence for selecting the appropriate therapy for each combination of genetic alterations, we would need randomized clinical trials lasting 14.4 million years.
The next generation of deterministic, multidimensional algorithmic clinical decision support systems for evidence-based personalized treatment planning is set to address this complex clinical challenge.
With 30 years of expertise in precision oncology, Dr. Petak will discuss his journey in the field and highlight the remarkable performance of Genomate. His presentation will showcase how computational intelligence transforms cancer treatment by enabling more precise, data-driven therapeutic decisions. Genomate’s technology enhances the ability to analyze molecular profiles, improving treatment selection, clinical trial optimization, and overall patient outcomes.
The Clinical Informatics Grand Rounds series is a platform for pioneering experts to share insights that drive innovation in cancer informatics. Dr. Petak’s participation highlights Genomate’s impact in advancing precision oncology and bridging the gap between complex molecular data and real-world clinical applications.
For more details about the event, visit Ci4CC’s website. Stay tuned for key takeaways!
.png)
